Introduction of HIV drug-resistance testing in clinical practice

被引：59

作者：

Rodríguez-Rosado, R ^{[1
]}

Briones, C ^{[1
]}

Soriano, V ^{[1
]}

机构：

[1] Inst Salud Carlos III, Hosp Carlos III, Infect Dis Serv, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 09期

关键词：

diagnosis; drug resistance; highly active antiretroviral therapy; viral load;

D O I：

10.1097/00002030-199906180-00001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1007 / 1014

页数：8

共 47 条

[21]

HENEINE W, 1998, ANTIVIRAL THERAPY S1, V3, P42

[22] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].

Hirsch, MS ;

Conway, B ;

D'Aquila, RT ;

Johnson, VA ;

Brun-Vézinet, F ;

Clotet, B ;

Demeter, LM ;

Hammer, SM ;

Jacobsen, DM ;

Kuritzkes, DR ;

Loveday, C ;

Mellors, JW ;

Vella, S ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991

[23] Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine [J].

Imrie, A ;

Beveridge, A ;

Genn, W ;

Vizzard, J ;

Cooper, DA .

JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1502-1506

[24] A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2′,3′-dideoxy-3′-thiacytidine [J].

Kemp, SD ;

Shi, CF ;

Bloor, S ;

Harrigan, PR ;

Mellors, JW ;

Larder, BA .

JOURNAL OF VIROLOGY, 1998, 72 (06) :5093-5098

[25] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[26]

LANIER R, 1998, ANTIVIR THER S, V3, P36

[27] POTENTIAL MECHANISM FOR SUSTAINED ANTIRETROVIRAL EFFICACY OF AZT-3TC COMBINATION THERAPY [J].

LARDER, BA ;

KEMP, SD ;

HARRIGAN, PR .

SCIENCE, 1995, 269 (5224) :696-699

[28] HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter [J].

Lee, CGL ;

Gottesman, MM ;

Cardarelli, CO ;

Ramachandra, M ;

Jeang, KT ;

Ambudkar, SV ;

Pastan, I ;

Dey, S .

BIOCHEMISTRY, 1998, 37 (11) :3594-3601

[29] Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: Reassessment of parameters affecting assay outcome [J].

Lew, J ;

Reichelderfer, P ;

Fowler, M ;

Bremer, J ;

Carrol, R ;

Cassol, S ;

Chernoff, D ;

Coombs, R ;

Cronin, M ;

Dickover, R ;

Fiscus, S ;

Herman, S ;

Jackson, B ;

Kornegay, J ;

Kovacs, A ;

McIntosh, K ;

Meyer, W ;

Michael, N ;

Mofenson, L ;

Moye, J ;

Quinn, T ;

Robb, M ;

Vahey, M ;

Weiser, B ;

Yeghiazarian, T .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (06) :1471-1479

[30]

Mas A, 1998, ANTIVIR THER, V3, P43

← 1 2 3 4 5 →